VEGF antagonist formulations suitable for intravitreal administration

Details for Australian Patent Application No. 2007261536 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Furfine, Eric; Dix, Daniel; Graham, Kenneth S.; Frye, Kelly

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007261536

PCT Pub. Number WO2007/149334

Priority 60/814,484 16.06.06 US

Filing date 14 June 2007

Wipo publication date 27 December 2007

Acceptance publication date 16 February 2012

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/149334 Priority application(s): WO2007/149334

16 February 2012 Application Accepted

  Published as AU-B-2007261536

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007261542-Method and system for monitoring nonoccurring events

2007261530-Serum-free media and their uses for chondrocyte expansion